跳转至内容
Merck
CN

A7223

白蛋白 人

recombinant, expressed in Pichia pastoris, 5% in aqueous buffer, ≥90% (SDS-PAGE)

别名:

Albagen™, rHSA

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C2936H4624N786O889S41
化学文摘社编号:
70024-90-7
分子量:
66471.53
UNSPSC Code:
12352202
NACRES:
NA.25
MDL number:
MFCD00081418

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

白蛋白 人, recombinant, expressed in Pichia pastoris, 5% in aqueous buffer, ≥90% (SDS-PAGE)

SMILES string

FC(F)(F)C(F)(F)C(F)(F)F

InChI

1S/C3F8/c4-1(5,2(6,7)8)3(9,10)11

InChI key

QYSGYZVSCZSLHT-UHFFFAOYSA-N

biological source

human

recombinant

expressed in Pichia pastoris

assay

≥90% (SDS-PAGE)

form

solution

mol wt

monomer ~67 kDa

concentration

5% in aqueous buffer

technique(s)

cell culture | mammalian: suitable

UniProt accession no.

P02768

shipped in

wet ice

storage temp.

2-8°C

Quality Level

200

Gene Information

human ... ALB(213)

正在寻找类似产品? 访问 产品对比指南

相关类别

Application

该重组变异建议用于：吸收、分散、代谢和排泄（ADME）药理学研究；细胞培养；药物递送研究；细胞冻存。

Biochem/physiol Actions

白蛋白是可见于动物体液和组织及部分植物种子的一类可溶性单体蛋白。 血清白蛋白可作为类固醇、脂肪酸和甲状腺激素的载体蛋白。 血清白蛋白在调节血液的胶体渗透压方面也至关重要。

General description

Asp N末端缺失的重组构建体。X射线晶体学证实了其与天然白蛋白的结构等同性。Asp N末端是主要的Cu2+和Ni2+ 螯合位点；其缺失消除了一个重要的抗原决定簇，让蛋白质具有低过敏源性。还可在Cys34处阻断，改善稳定性、单体含量和均质性。

Other Notes

更多信息参见人血清白蛋白。

Physical form

磷酸盐缓冲盐水溶液，含有4 mM辛酸钠和 4 mM N-乙酰色氨酸。

Legal Information

Albagen is a trademark of Albumin Therapeutics, LLC.

存储类别

12 - Non Combustible Liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

常规特殊物品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000485564
0000485564
0000475902
0000475902
0000467737

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  3. What is the concentration of Product A7223, Albumin human - recombinant?

    The concentration of this solution is 50 mg/mL.

  4. How many milliliters are in the 1 gram package size of Product A7223, Albumin human - recombinant?

    There are 20 mL of albumin solution in the 1 gram package size.

  5. What is the molecular mass of the recombinant albumin used in preparing Product A7223, Albumin human - recombinant?

    This recombinant protein contains 584 amino acid residues (66,357 Dalton) derived from the prototypical human serum albumin sequence, Gene Bank Accession No. M12523, with a single deletion of the N-terminal residue (Asp).  The N-terminal deletion of the Asp reduces the affinity by which nickel and copper bind to the protein.  Otherwise, the biological properties are identical as for the full-length protein.

  6. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  7. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  8. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

Lien-Yu Hung et al.
Biomicrofluidics, 12(5), 054108-054108 (2018-10-23)
Cancer is the most serious disease worldwide, and ovarian cancer (OvCa) is the second most common type of gynecological cancer. There is consequently an urgent need for early-stage detection of OvCa, which requires affinity reagent biomarkers for OvCa. Systematic evolution
Jonah C Rosch et al.
Cellular and molecular bioengineering, 15(2), 161-173 (2022-04-12)
Short interfering RNAs (siRNAs) are potent nucleic acid-based drugs designed to target disease driving genes that may otherwise be undruggable with small molecules. However, therapeutic potential of siRNA in vivo is limited by poor pharmacokinetic properties, including rapid renal clearance
Jay Jagannathan et al.
Journal of neurosurgery, 109(3), 547-552 (2008-09-02)
Convection-enhanced delivery (CED) is increasingly used to investigate new treatments for central nervous system disorders. Although the properties of CED are well established in normal gray and white matter central nervous system structures, the effects on drug distribution imposed by
Mauricio Sendeski et al.
Radiology, 251(3), 697-704 (2009-04-16)
To determine whether a type of contrast medium (CM), iodixanol, modifies outer medullary descending vasa recta (DVR) vasoreactivity and nitric oxide (NO) production in isolated microperfused DVR. Animal handling conformed to the Animal Care Committee Guidelines of all participating institutions.
Abdullah Hussain et al.
Immunology, 128(2), 236-244 (2009-09-11)
Anti-proteinase 3 antibodies are implicated in the pathogenesis of small vessel vasculitis. These are primarily immunoglobulin G (IgG), with different subclasses predominating at different stages of disease. However, little is known of their respective roles in pathogenesis. We have previously

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持